Patent agent Adelaide Leitzel and attorney Neal Roach published “Is the CRISPR Treat Worth Two Licenses?” in the March 2018 issue of les Nouvelles, the Journal of the Licensing Executives Society International.

The article discusses the battle between scientists at the University of California Berkley and the Broad Institute of Harvard and MIT for DNA technology called CRISPR. The genome editing technique has far-reaching applications in medicine and agriculture.